Quick Takeaways
- Rosalind Advisors, Inc. filed SCHEDULE 13G/A for Cellectar Biosciences, Inc. Common Shares (CLRB).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2024.
Rosalind Advisors, Inc. - 31 Dec 2024 SCHEDULE 13G/A Report for Cellectar Biosciences, Inc. Common Shares (CLRB)
- Filing Manager
- Rosalind Advisors, Inc.
- Reporting Manager
- Rosalind Advisors, Inc.
- Symbol
- CLRB
- Shares outstanding
- 75,482,273 shares
- Disclosed Ownership
- 7,472,745 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 03 Feb 2025, 16:57:33 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 10 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Rosalind Advisors, Inc. disclosed 9.9% ownership in Cellectar Biosciences, Inc. Common Shares (CLRB) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Feb 2025, 16:57.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (5)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 9.9% | 7,472,745 | 0 | 7,472,745 | Steven Salamon | President | |
| SALAMON STEVEN A J | 9.9% | 7,472,745 | 0 | 7,472,745 | Steven Salamon | Steven Salamon | |
| Aharon Gil | 9.9% | 7,472,745 | 3,900 | 7,472,745 | Gil Aharon | Gil Aharon | |
| Rosalind Master Fund L.P. | 7.7% | 5,592,395 | 0 | 5,592,395 | Mike McDonald | Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund) | |
| Rosalind Opportunities Fund I L.P. | 2.6% | 1,880,350 | 0 | 1,880,350 | Steven Salamon | Director, Rosalind Opportunities Fund I GP. Inc. (as General Partners to Rosalind Opportunities Fund I) |